Get Insights Into How Blockchain Can Improve Pharma and Biotech Manufacturing
Blockchain technology (more precisely, “Distributed Ledger Technology” or DLT) is set to substantially impact the inner gears of drug manufacturing by aligning CDMOs and drug developers, increasing transparency in the supply chain, improving hand-offs, and preventing fraud/counterfeiting.
In this paper we explore theoretical blockchain DLT applications between a drug developer and CDMO using the drug product fill/finish ecosystem of Argonaut Manufacturing Services.
Read more about using blockchain and DLT technologies for pharma and biotech manufacturing and download the full white paper by Clicking Here. You can read the first page below (click the image to see a larger version):
The world’s leading fill/finish technology is available for you in our facilities. Equipped with advanced robotics, our automated state-of-the-art line is specially designed to reduce risk and maximize fill yield.